# Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/second-line-single-agent-chemotherapy-in-human-epidermal-growth-factor-receptor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Fabio Puglisi,Daniel Rea,Michel Kroes,P. Pronzato |
| Citations | 9 |
| DOI | 10.1016/j.ctrv.2015.11.012 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://research.birmingham.ac.uk/portal/en/publications/secondline-singleagent-chemotherapy-in-human-epidermal-growth-factor-receptor-2negative-metastatic-breast-cancer(d7ec6678-7984-4af8-9549-2ce2a964311b).html |
| OpenAlex ID | https://openalex.org/W2195516725 |
| PMID | 26827691 |
| Type | review |
| Year | 2015 |

## Paper authors

- [Michel Kroes](https://scholariq.org/researchers/michel-kroes/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.